The protein stability analysis market comprises of products and services offered for evaluating the physical and chemical stability of protein-based drugs, biotherapeutics, and vaccine candidates. Protein stability analysis helps identify physicochemical changes during formulation, manufacturing, storage, and distribution that may affect protein conformation and biological activity. The increasing investments in biologics and biosimilars development by pharmaceutical companies is driving the demand for analytical tools and testing services to evaluate protein stability under various environmental conditions. Protein stability analysis provides critical information required for developing a robust protein drug product with a defined shelf life. It facilitates optimizing the formulation strategies to prevent protein aggregation and degradation during long-term storage.
Key Takeaways:
Key players operating in the Protein Stability Analysis Market Growth are Thermo Fisher Scientific, Inc., Enzo Biochem, Inc., PerkinElmer Inc., NanoTemper, GE Healthcare, HORIBA, Ltd., Malvern Panalytical Ltd., Agilent Technologies, Inc., SETARAM Instrumentation, Unchained Labs, Waters Corporation, and Applied Photophysics Ltd. These leading players are focusing on new product launches and mergers & acquisitions to expand their service portfolio and geographic presence in high growth markets.
The growing R&D investment in biologics by pharmaceutical and biotechnology companies presents significant opportunities for players in the protein stability analysis market. The COVID-19 pandemic has further accelerated the research on protein-based vaccines and monoclonal antibody therapies, fueling demand for analytical capabilities to ensure the stability of these product candidates.
Major players are actively pursuing global expansion strategies through collaborations with Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) involved in biologics and vaccine development programs worldwide. This allows them to capitalize on the increasing outsourcing of stability testing activities by biopharma firms.
Market drivers:
One of the key drivers of the protein stability analysis market is the rising demand for generic versions of biologics or biosimilars. Developing biosimilars require extensive comparative characterization and physico-chemical analysis, including protein stability studies, to demonstrate similarity with the reference product.
Furthermore, the increasing R&D investments by pharmaceutical companies in protein-based drugs and vaccines is fueling the need for stability testing technologies and services that can evaluate protein conformational changes accurately under various stress conditions over the desired shelf life.
Market restraints:
High capital investment requirements for procuring analytical instruments for stability testing pose significant challenges, especially for small and mid-sized players. Moreover, the complex nature of protein structures makes stability evaluation challenging. Reproducibility of results across different analytical techniques can also be an issue in some cases. Strict regulatory norms by FDA and EMA for protein stability data submissions also restrain market growth to some extent.
Segment Analysis
The analytical equipment segment is dominating the protein stability analysis market currently owing to high demand from pharmaceutical and biotechnology companies for accurate and precise protein stability analysis. The analytical equipment segment includes HPLC, spectrophotometers, DSC, SPR, and others. These analytical tools aid in monitoring protein stability through various parameters like temperature, pH, formulation conditions etc. The consumables segment is expected to witness high growth during the forecast period due to rising consumption of reagents, assay kits, microplates and other disposables used while carrying out protein stability testing.
Global Analysis
North America region currently holds the major share in the global protein stability analysis market due to high funding for research and development activities from government as well as private sector. Presence of leading market players and availability of advanced healthcare infrastructure also contributes to the large market size of the region. Asia Pacific is anticipated to be the fastest growing regional market during the forecast period attributed to increasing outsourcing of pharmaceutical research to emerging countries like India and China coupled with growing biotechnology industry.
Get more insights on Protein Stability Analysis Market
Comments
0 comment